Rsv Vaccine Pref3, Recombinant Dosage

Medically reviewed by Drugs.com. Last updated on Aug 8, 2023.

Usual Adult Dose for Respiratory Syncytial Virus

0.5 mL IM as a single dose.

Uses:

• For active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals aged 50 to 59 years with an increased risk of LRTD caused by RSV
• For active immunization for the prevention of lower respiratory tract disease LRTD caused by respiratory syncytial virus RSV individuals 60 years of age and older.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS: History of severe allergic reaction to any component of the vaccine.

Safety and efficacy have not been established in patients younger than 50 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• For IM administration only.

• Administer immediately or store in the refrigerator between 2C and 8C (36F to 46F) or at room temperature for up to 4 hours prior to use.
• Protect vials from light.
• Discard reconstituted vaccine if not used within 4 hours.
• Do not freeze. Discard if the vaccine is frozen.

• The manufacturer's product information should be consulted.

• Read Vaccine Information Statement (VIS) provided or available at (www.cdc.gov/vaccines).
• Discuss and report possible adverse reactions with the healthcare provider.

Frequently asked questions

• What is the difference between Arexvy and Abrysvo?
• What are the symptoms of RSV (respiratory syncytial virus)?

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer